EBA181

EBA181 (PF3D7_0102500) is a microneme-localized member of the P. falciparum erythrocyte binding-like family that mediates a sialic acid-dependent, trypsin-resistant/chymotrypsin-sensitive pathway of merozoite invasion into erythrocytes (PMID:12556470). It engages erythrocyte surface receptors through its region II binding domain, where natural polymorphisms modulate the level of erythrocyte binding in a manner that correlates with invasion function (PMID:19204093); its N-terminal region binds specific erythrocyte surface proteins, and peptides from this region block invasion in vitro (PMID:15820749). On the host side EBA181 recognizes Neu5Ac and Neu5Gc sialic acids and an ~100 kDa erythrocyte membrane protein, and it binds the erythrocyte cytoskeletal adaptor 4.1R through its 10 kDa domain (PMID:17087826, PMID:41198968). Rather than acting in isolation, EBA181 functionally cooperates with the PfRh invasion ligands: its physical association with Rh2b (KD ~3 µM) (PMID:41198968) and the finding that eba181 knockout abolishes anti-PfRh2a/b antibody inhibition and drives compensatory upregulation of PfRh genes (PMID:21149582) place it within an interdependent EBL/PfRh invasion network. EBA181 is dispensable in some strains (disruptable in W2mef but not 3D7) (PMID:12556470), is expressed stochastically among schizonts consistent with epigenetic control (PMID:35637187), and is a target of naturally acquired invasion-inhibitory antibodies whose evasion is aided by variation in EBA181 expression (PMID:23776178). Its RIII-V region is intrinsically disordered (PMID:25288451).

1. 2003 High

   Established EBA181 as a bona fide invasion ligand by placing it in the micronemes and defining the biochemical signature of its erythrocyte binding, answering where and how the protein acts during invasion.

   Evidence Immunofluorescence co-localization with EBA-175, erythrocyte binding assays with enzyme-treated and glycophorin B-deficient cells, and gene disruption in W2mef versus 3D7

   PMID:12556470

   Open questions at the time

   • Molecular identity of the erythrocyte receptor left undefined beyond being distinct from glycophorin B
   • Basis of strain-dependent dispensability (W2mef vs 3D7) not resolved
2. 2004 High

   Addressed whether sequence variation in the binding domain changes what EBA181 recognizes, testing how the parasite might diversify receptor usage.

   Evidence Sequencing of region II from natural isolates and CHO-cell surface expression of region II variants assayed against enzyme-treated erythrocytes

   PMID:14983041

   Open questions at the time

   • Later work reinterpreted these effects as altering binding level rather than specificity
   • Receptor(s) recognized by each variant not identified
3. 2005 Medium

   Mapped functional binding activity to the N-terminal region and demonstrated its causal role in invasion by peptide inhibition.

   Evidence Synthetic 20-mer peptide binding to ~53 and ~33 kDa erythrocyte receptors with saturable kinetics and in vitro merozoite invasion inhibition

   PMID:15820749

   Open questions at the time

   • The ~53/~33 kDa receptor proteins were not molecularly identified
   • Peptide inhibition does not establish which region drives receptor engagement in the native protein
4. 2006 Medium

   Identified an intracellular host partner, showing EBA181 engages the erythrocyte cytoskeletal adaptor 4.1R and hinting at a role beyond a simple surface receptor.

   Evidence Blot overlay and histidine pull-down assays with recombinant 4.1R domains and the EBA181 binding region

   PMID:17087826

   Open questions at the time

   • Functional consequence of the 4.1R interaction during invasion not tested
   • In vitro binding not confirmed in situ within intact erythrocytes
5. 2009 Medium

   Refined the earlier polymorphism model, showing region II variation tunes binding strength rather than specificity and that binding level tracks with invasion function.

   Evidence Erythrocyte binding assays with recombinant region II from polymorphic isolates paired with invasion assays of variant parasite lines

   PMID:19204093

   Open questions at the time

   • Structural basis for polymorphism-dependent binding-level differences not resolved
   • Single receptor identity underlying the binding still unknown
6. 2010 High

   Placed EBA181 in a functionally interdependent network with PfRh ligands, explaining how EBL and PfRh pathways cooperate and compensate during invasion.

   Evidence Single/double knockouts of eba genes, anti-PfRh2a/b antibody invasion inhibition assays, and quantitative PfRh transcriptional analysis

   PMID:21149582

   Open questions at the time

   • Molecular basis of the functional link between EBA181 and PfRh2a/b left unresolved at this stage
   • Whether the cooperation is physical or purely functional not determined here
7. 2013 Medium

   Showed EBA181 is a heparin-binding apical protein, adding a biochemical property relevant to invasion-blocking by sulfated glycans.

   Evidence Heparin affinity chromatography with ligand-specific immunoblotting and immunofluorescence localization to the merozoite apical tip

   PMID:24212193

   Open questions at the time

   • Whether heparin binding is physiologically relevant or an in vitro cross-reactivity not established
   • Heparin-binding site within EBA181 not mapped
8. 2013 High

   Demonstrated immunological relevance by showing EBA181 is a target of naturally acquired inhibitory antibodies and that its variable expression aids immune evasion.

   Evidence Invasion inhibition assays with plasma from malaria-exposed individuals against parental and eba knockout lines from two populations

   PMID:23776178

   Open questions at the time

   • Epitopes recognized by protective antibodies not defined
   • Contribution of EBA181 antibodies to clinical protection in vivo not established
9. 2014 High

   Characterized the RIII-V region as intrinsically disordered, informing how this part of the protein behaves structurally.

   Evidence Disorder prediction and atomic-resolution NMR of the recombinant EBA181 residue 945-1097 construct

   PMID:25288451

   Open questions at the time

   • Functional role of the disordered RIII-V region during invasion not defined
   • Whether disorder mediates partner interactions untested
10. 2022 Medium

    Revealed that eba181 transcription is stochastically variable across single schizonts, implicating epigenetic regulation as a source of the expression variation underlying immune evasion.

    Evidence Single-cell RNA sequencing validated by quantitative RT-PCR and RNA-FISH

    PMID:35637187

    Open questions at the time

    • The specific epigenetic marks or regulators controlling eba181 not identified
    • Direct link between transcriptional variation and invasion phenotype not tested in this study
11. 2025 Medium

    Provided direct affinity measurements defining EBA181's molecular partners, including a physical Rh2b interaction that substantiates the earlier functional EBL/PfRh cooperation.

    Evidence Surface Plasmon Resonance of recombinant EBA181 against Neu5Ac/Neu5Gc sialic acids, Rh2b protein (KD ~3 µM), and erythrocyte membrane fractions

    PMID:41198968

    Open questions at the time

    • Band 3 as the ~100 kDa erythrocyte receptor remains putative
    • Single-method (SPR) measurements not independently confirmed
    • Structural basis of the EBA181-Rh2b interaction unknown

• The definitive molecular identity of the erythrocyte surface receptor for EBA181 and the structural basis of its cooperation with PfRh2b remain unresolved.
• No confirmed erythrocyte receptor identity (Band 3 still putative)
• No structure of an EBA181-receptor or EBA181-Rh2b complex
• Functional role of 4.1R binding and disordered RIII-V region in invasion undefined